Purigen Biosystems
Innovative products that offer a truly transformative automated solution for DNA and RNA purification.
Launch date
Employees
Market cap
-
Enterprise valuation
$138—206m (Dealroom.co estimates Apr 2021.)
Pleasanton California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $830k | Debt | |
| N/A | $200k | Debt | |
| N/A | $13.0m | Late VC | |
$18.2m | Series A | ||
$26.4m | Series B | ||
| N/A | $34.4m | Late VC | |
* | $32.0m | Acquisition | |
| Total Funding | $92.0m | ||
Related Content
Recent News about Purigen Biosystems
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.